Skip to content

Dysfunctional Hemoglobin

Dysfunctional Hemoglobin Pulse Co-ox

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02262195
Enrollment
62
Registered
2014-10-10
Start date
2014-10-31
Completion date
2015-03-31
Last updated
2015-04-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Elevated Levels of Carboxyhemoglobin and Methemoglobin

Brief summary

The purpose of the study is to determine if a new pulse oximeter accurately detects carboxyhemoglobin and methemoglobin when intentionally increased in the blood.

Interventions

OTHERElevated levels of carboxyhemoglobin

Comparison of pulse co-oximeters

Sponsors

University of California, San Francisco
CollaboratorOTHER
Nonin Medical, Inc
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 45 Years
Healthy volunteers
Yes

Inclusion criteria

* Subjects does not have significant medical problems * Subject is willing to provide written informed consent * Subject is between 18 and 45 years of age

Exclusion criteria

* Has a BMI greater than 31 * Has had any relevant injury at the sensor location site * Has deformities or abnormalities that may prevent proper application of the device under test * Has a known respiratory condition * Is currently a smoker * Has a known heart or cardiovascular condition * Is currently pregnant * Is female and actively trying to get pregnant * Has a clotting disorder * Is known to have a hemoglobinopathy such as (anemia, bilirubinemia, sickle-cell anemia, inherited or congenital methemoglobinemia) * The subject has a COHb greater than 3% or MetHb greater than 2% * Has taken blood thinners or medication with aspirin within the last 24 hours * Has unacceptable collateral circulation from the ulnar artery * Has donated more than 300 mL of blood within one month prior to start of study * Is unwilling or unable to provide written informed consent to participate in the study * Is unwilling or unable to comply with the study procedures * Has another health condition which in the opinion of the principal investigator makes him/her unsuitable for testing

Design outcomes

Primary

MeasureTime frame
Evaluate carboxyhemoglobin over the range of 0-15 percent as assessed by co-oximetry4 hours
Evaluate methemoglobin over the range of 0-15 percent as assessed by co-oximetry4 hours

Secondary

MeasureTime frame
Determine oxygen saturation accuracy in conditions of elevated carboxyhemoglobin4 hours
Determine oxygen saturation accuracy in conditions of elevated methemoglobin4 hours

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026